Marshfield Clinic Innovates and Pivots to Provide Quality and Cost Effective Care in Rural Health
With a patient network spanning more than 45,000 square feet, Susan Turney, M.D., MS, FACP, FACPME, Chief Executive Officer of Marshfield Clinic Health System, faces daily challenges in providing rural healthcare. COVID-19 further exacerbated existing issues but that did not deter her from continuing to put patient needs and care at the forefront. Through her ambitious moonshot of enriching the lives of those in her communities, Dr. Turney has implemented new care models in an effort to extend care beyond her hospitals’ physical walls.
Join A&M’s David Shulkin, M.D., Senior Advisor, and John McLean, Managing Director, as they sit down with Dr. Turney to hear how she has leveraged her systems’ capabilities and data to most efficiently and effectively meet the needs of her patients. This discussion brings to light how Dr. Turney has truly impacted the lives of her patients and continues to be a leader in continuing to further the quality of rural healthcare.
Subscribe:
Click here to access all episodes in this podcast.
Access Reimagined: Meeting Evolving Workforce Expectations While Expanding Patient Reach
April 23, 2026
Redesign the system. Realign incentives. Reimagine access. Patrick J. Byrne, M.D., Chief of Cleveland Clinic's Integrated Surgical, and Lisa Ishii, M.D., M.H.S, SVP of Operations for Johns Hopkins Health System join A&M Healthcare Industry Group's Brian Giessler to share their vision for redesigning healthcare to deliver the right care at the right time.
LS: Next Growth Curve
April 22, 2026
Developed markets are facing structural headwinds, such as affordability constraints, pricing reform, as demographic saturation and slower volume growth are limiting expansion and resulting a moderating growth rate. In contrast, emerging markets are entering a phase of healthcare formalization and access expansion driven by rising chronic disease burden and government prioritization of pharmaceuticals
The Next Growth Curve: How Biopharma Can Win in Developing Markets
April 20, 2026
Developed markets are facing structural headwinds, such as affordability constraints, pricing reform, as demographic saturation and slower volume growth are limiting expansion and resulting a moderating growth rate. In contrast, emerging markets are entering a phase of healthcare formalization and access expansion driven by rising chronic disease burden and government prioritization of pharmaceuticals
Episode 1: Chris Ellis, Co-founder and CEO, Thatch
April 2, 2026
This podcast series presents conversations with Healthcare Leaders on strategies shaping health plan transformation, today.
